找化学品上960化工网!
960化工网

赖诺普利 | 83915-83-7

赖诺普利
Lisinopril dihydrate
83915-83-7
C21H33N3O6
423.503226041794
如需查看该化合物的详细结构式,mol文件,smile,InChi 请点击:赖诺普利结构式
5362118
赖诺普利价格
简介
Lisinopri dihydrate (MK-521 dihydrate) 是血管紧张素转化酶抑制剂,可作用于高血压,充血性心力衰竭和心脏病等。
名称和标识符
MDL MFCD01698825
InChIKey BAVDEDVBIHTHJQ-UVJOBNTFSA-N
Inchi 1S/C21H31N3O5.H2O/c22-13-5-4-9-16(19(25)24-14-6-10-18(24)21(28)29)23-17(20(26)27)12-11-15-7-2-1-3-8-15;/h1-3,7-8,16-18,23H,4-6,9-14,22H2,(H,26,27)(H,28,29);1H2/t16-,17-,18-;/m0./s1
SMILES C(N1CCC[C@H]1C(=O)O)(=O)[C@H](CCCCN)N[C@H](C(=O)O)CCC1C=CC=CC=1.O
别名信息
- 中文别名 -
  • 赖诺普利
  • 1-[N2-((S)-羰基)-3-苯丙基]-L-赖氨酰基-L-脯氨酸
  • 赖诺普利二水合物
  • Lisinopril Dihydrate 赖诺普利二水合物
  • 赖诺普利 USP标准品
  • 赖诺普利 标准品
  • 赖诺普利-D5
  • 赖诺普利二水
  • 赖诺普利二水标准品
  • 赖诺普利二水合物 EP标准品
  • 赖诺普利二水物
  • 赖诺普利水合物
  • 纳豆激酶
  • 1-[Nα-[(S)-1-羧基-3-苯丙基]-L-赖氨酰基]-L-脯氨酸 二水合物
  • 赖诺普利系统适应性
- 英文别名 -
  • Lisinopril
  • (S)-1-(N2-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline dihydrate
  • Lisinopril Dihydrate
  • (S)-1-[N2-(1-carboxy-3-phenylpropyl)-L-lysyl]-L-proline dihydrate
  • (S)-Lisinopril
  • Bis(2,4-dinitrophenyl)carbonate
  • Lisinopril (dihydrate)
  • Lisinopril Hydrate
  • MK-521
  • 1-[Nα-[(S)-1-Carboxy-3-phenylpropyl]-L-lysyl]-L-proline Dihydrate
  • (S)-1-[N2-(1-carboxy-3-phenylpropyl)-lysyl-proline dihydrate
  • MK-521 dihydrate
  • Lisinopril dihydrate
  • L-Proline, 1-[N2-(1-carboxy-3-phenylpropyl)-L-lysyl]-, dihydrate, (S)- (ZCI)
  • L-Proline, N2-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-, dihydrate (9CI)
  • Zestril (TN)
  • LISINOPRIL COMPONENT OF ZESTORETIC
  • AC-6226
  • Prinivil (TN)
  • LISINOPRIL DIHYDRATE [MI]
  • SR-01000801314-3
  • F20515
  • Lisinopril Dihydrate
  • N2-[(1S)-1-Carboxy-3-phenylpropyl]-L-lysyl-L-proline dihydrate
  • (S)-1-[N2-(1-Carboxy-3-phenylpropyl)-L-lysyl]-L-proline dihydrate
  • Tox21_110798_1
  • CHEBI:6503
  • KS-1078
  • AKOS015950799
  • Q47495698
  • LISINOPRIL COMPONENT OF PRINZIDE
  • Lisinopril for system suitability A, European Pharmacopoeia (EP) Reference Standard
  • LISINOPRIL DIHYDRATE [WHO-DD]
  • 83915-83-7
  • HMS3712N04
  • BL164629
  • Lisinopril, United States Pharmacopeia (USP) Reference Standard
  • NSC 758151
  • Lisinopril dihydrate, European Pharmacopoeia (EP) Reference Standard
  • L-Proline, N2-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-, hydrate (1:2)
  • HMS1568N04
  • Tox21_110798
  • HY-18206A
  • (S)-1-(N(sup 2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline dihydrate
  • L-Proline, 1-(N2-(1-carboxy-3-phenylpropyl)-L-lysyl)-, dihydrate, (S)-
  • D00362
  • CHEMBL419213
  • LISINOPRIL HYDRATE [JAN]
  • Ranolip
  • LISINOPRIL [ORANGE BOOK]
  • SCHEMBL542591
  • Lisinopril hydrate (JP17)
  • CAS-83915-83-7
  • (S)-1-(N(2)-(1-carboxy-3-phenylpropyl)-L-lysyl)-L-proline dihydrate
  • UNII-E7199S1YWR
  • LISINOPRIL [USP IMPURITY]
  • NSC 751176
  • LISINOPRIL DIHYDRATE [EP MONOGRAPH]
  • N(2)-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-proline dihydrate
  • LISINOPRIL [USAN]
  • DTXCID0025600
  • DTXSID2045600
  • Lisinopril hydrate
  • Lisinopril (USP)
  • S)-1-[N2-(1-carboxy-3-phenylpropyl)-lysyl-proline dihydrate
  • lisinopril-dihydrat
  • L-Proline, 1-(N(sup 2)-(1-carboxy-3-phenylpropyl)-L-lysyl)-, dihydrate, (S)-
  • (2S)-1-[(2S)-6-amino-2-{[(1S)-1-carboxy-3-phenylpropyl]amino}hexanoyl]pyrrolidine-2-carboxylic acid dihydrate
  • (S)-1-((S)-6-Amino-2-(((S)-1-carboxy-3-phenylpropyl)amino)hexanoyl)pyrrolidine-2-carboxylicaciddihydrate
  • MFCD01698825
  • NCGC00179623-04
  • MK-521 (dihydrate)
  • NCGC00017141-01
  • SR-01000801314
  • PRINZIDE COMPONENT LISINOPRIL
  • Lisinopril, >=98% (HPLC)
  • E7199S1YWR
  • CCG-220301
  • EN300-19652794
  • Lisinopril for peak identification, European Pharmacopoeia (EP) Reference Standard
  • (S)-1-((S)-6-Amino-2-(((S)-1-carboxy-3-phenylpropyl)amino)hexanoyl)pyrrolidine-2-carboxylic acid dihydrate
  • 1-(N(sup 2)-((S)-1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline dihydrate
  • Prestwick_613
  • Lisinopril [USAN:USP:INN:BAN:JAN]
  • LISINOPRIL [USP-RS]
  • Lisinopril, Pharmaceutical Secondary Standard
  • Certified Reference Material
  • LISINOPRIL [HSDB]
  • 1ST10889W
  • (S)-Lisinopril Dihydrate
  • LISINOPRIL [USP MONOGRAPH]
  • LISINOPRIL [MART.]
  • L-Proline, N2-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-, dihydrate
  • Lisinopril dihydrate, British Pharmacopoeia (BP) Reference Standard
  • ZESTORETIC COMPONENT LISINOPRIL
  • Renacor
  • HMS2095N04
  • Lisinopril for system suitability
物化性质
实验特性
Merck 5516
折射率 -45 ° (C=1, 0.25mol/L Zinc Acetate Buffer)
沸点 666.4°C at 760 mmHg
熔点 148°C(lit.)
溶解度 H2O: ≥10 mg/mL
颜色与性状 略有异臭的白色或类白色结晶粉末
稳定性 Hygroscopic
溶解性 (mg/m1)
敏感性 对热敏感
酸度系数(pKa) 2.5, 4.0, 6.7, 10.1(at 25℃)
比旋光度 25405 -120° (c = 1 in 0.25M pH 6.4 zinc acetate); 25436 -96° (c = 1 in 0.25M pH 6.4 zinc acetate)
计算特性
精确分子量 441.24750046g/mol
氢键供体数量 6
氢键受体数量 10
可旋转化学键数量 13
同位素质量 441.24750046g/mol
重原子数量 31
复杂度 550
同位素原子数量 0
确定原子立构中心数量 3
不确定原子立构中心数量 0
确定化学键立构中心数量 0
不确定化学键立构中心数量 0
共价键单元数量 3
表面电荷 0
拓扑分子极性表面积 135
国际标准相关数据
EINECS 278-488-1
专业数据库参考
PubChemId 5362118
参考资料
Reaxys RN 4276619
Beilstein MFCD01698825
赖诺普利推荐生产厂家
赖诺普利相关资讯
960化工网为您提供赖诺普利专业化合物百科信息,包括中文名,英文名,分子式,分子量,以及该化合物的CasNo.:83915-83-7,和相关理化性质;并提供了优质生产厂家信息包括厂家名称和联系方式等
平台客服 平台客服

平台在线客服